IVF Services Market
Biotechnology

IVF Services Market Scope 2020: Know the COVID-19 Impact on Biotechnology Sector by 2027

 

IVF or In Vitro Fertilization is a hyped reproductive technology in which the ova from woman’s ovaries and the sperm sample from a male is retrieved and manually diffused externally in a laboratory glass dish. After the fertilization these fertile eggs undergo embryo culture for a few days and transferred to the same or another woman’s uterus in order to establish a successful pregnancy.  

The most notable market participants are Max Healthcare, Bloom IVF, CCRM Fertility., OXFORD FERTILITY, Create Health (Create Fertility), Medicover, Aevitas Fertility Clinic, BIOART Fertility Clinic, Prelude Fertility, Inc. and Gift ov life among others, occupying a considerable share of the market owing to their offerings to the market.

Medicover, and Max Healthcare Notable Market Participants in IVF Services Market

Market players are involved in offering the services that contribute to quality enhancement for services and cost efficiency within healthcare services. For instance, in January 2020, Ferring Pharmaceuticals and CCRM has announced the launch of Fertility House Calls, in the Greater Denver metro area, a new service that provides a simple, convenient way to explore fertility treatment options from home..

Prominent players in IVF services market are focusing on majorly on inorganic strategies such as acquisitions and others to garner their significance and remain competitive in the market. Few of the important key developments from the industry are mentioned below:

Year

News

2020

Carrot Fertility has completed partnership with CCRM Fertility. This partnership will greatly expand access to high-quality fertility care for prospective parents who have Carrot as a workplace benefit

2019

Prelude announced a partnership with Inception Fertility .The partnership made Prelude the largest fertility services provider in the U.S and added Aspire Fertility clinics to the Prelude Network

2018

The company has already launched Medicover Fertility in India in 2016 and have already grown to 15 fertility clinics across 10 cities in India. In 2018, the company has launched 15 more fertility clinics in India with state-of-the-art fertility clinic in Hyderabad

2017

Prelude Fertility has signed the definitive agreement to acquire Vivere Health and its flagship partner, the Houston Fertility Institute (HFI). Acquiring Vivere, including HFI, demonstrates about business expansion Prelude Fertility